Objective: To study the prevalence of vitamin B 6 deficiency in common variable immunodeficiency and the impact of vitamin B 6 supplementation on immune function in the disorder. Design: Open, non-blinded. Setting: Medical School Hannover, Hannover, Germany. Subjects: Plasma vitamin B 6 concentrations were measured in all the 54 common variable immunodeficiency (CVID) patients visiting our outpatients' clinics in 2005. Interventions: The 17 patients with a decreased vitamin B 6 concentration were recommended to take 50 mg of vitamin B 6 /day for 3 months. Then, vitamin B 6 concentrations, absolute number of lymphocyte populations and immunoglobulin concentrations were controlled. Results: Vitamin B 6 concentrations were reduced in 17/54 patients. All 11/17 patients following our advice to substitute vitamin B 6 had normal vitamin B 6 plasma concentrations 3 months later. In parallel, the number of CD4 þ T cells significantly increased. In contrast, concentrations of serum immunoglobulins were not improved. Conclusions: Vitamin B 6 deficiency is common in CVID. The vitamin deficiency is not the cause of CVID and vitamin supplementation does not relieve humoral immunodeficiency. Nevertheless, vitamin B 6 should be measured in CVID to avoid possible long-term complications of its deficiency.
Introduction
Common variable immunodeficiency (CVID) is a primary immunodeficiency with a prevalence between 1:20 000 and 1:100 000 and is characterized by hypogammaglobulinemia and recurrent bacterial infections, predominantly of the airways (Kainulainen et al., 2001) . So far, approximately 10-20% of the cases can be explained by gene mutations affecting interaction of B and T cells, in particular in the molecules ICOS, CD19, BAFF and TACI (Grimbacher et al., 2003; Castigli et al., 2005; Salzer et al., 2005) . However, the etiology of CVID remains unclear in the majority of patients. CVID usually develops in the second or third decade of life, so that a subset of CVID may not be of genetic origin, but could also be induced by infectious agents or other environmental factors.
Vitamin B 6 is required as a coenzyme for numerous reactions in the human body. Its deficiency causes blood, skin, and nerve changes and possibly coronary artery disease (Friso et al., 2004) . Homocysteine metabolism is dependent on vitamin B 6 , and high homocysteine levels can result from its deficiency (Booth and Wang, 2000) .
Vitamin B 6 precursors pyridoxine, pyridoxamine, and pyridoxal are absorbed and transported into hepatic cells and are converted into the active coenzyme pyridoxal 5 0 -phosphate (PLP). PLP either remains in the hepatocyte, where it is bound to an apoenzyme, or it is released into the serum, where it is bound to albumin. Vitamin B 6 deficiency can be caused by malabsorption or malnutrition and appears to be associated with immunodeficiency. Animal models have revealed that vitamin B 6 depletion impaired both humoral and cellular immune responses. Lymphocyte differentiation may be altered and delayed-type hypersensitivity responses reduced (Trakatellis et al., 1992; Frydas et al., 1999) . In HIV-infected patients, substitution of multivitamins that included vitamin B 6 delayed the progression of disease (Fawzi et al., 2004) . In elderly and uremic patients, vitamin B 6 reduction probably is the cause for susceptibility to infections (Rall and Meydani, 1993) .
As vitamin B 6 is required to maintain the function of the immune system, we wanted to study whether deficiency of vitamin B 6 was common in CVID.
Subjects and methods

Subjects
Fifty-four patients with CVID (30 female, 24 male) visiting our outpatients' clinics for adults were recruited. CVID was defined as reduction of serum IgG (lower than 7 g/l), recurrent bacterial airway infections and poor response to vaccinations. All patients gave written consent to participate in a study approved by our local ethical committee. Fifty-two patients were German Caucasians and two were of Turkish origin. Mean age was 44 (range 21-76) years.
All the patients answered a questionnaire on number of infections and antibiotic treatments within the last 12 months before inclusion into the study. Furthermore, paresthesia, nausea, smoking habits, diets, frequency of bowel movements were recorded. Alcohol abuse was denied by all the patients, and there were no vegetarians. None of the patients was treated with theophylline or isoniazid at the time vitamin B 6 concentrations were determined.
Laboratory
In all patients, plasma vitamin B 6 concentration was measured using high-performance liquid chromatography. In parallel, CD4, CD8, CD20 and CD16 count was analyzed using flow cytometry, concentrations of IgG including its subclasses, IgA and IgM were determined using nephelometry (Behring Nephelometer Analyzer II).
Substitution of vitamin B 6
All patients received regular subcutaneous or intravenous substitution of immunoglobulins. Participants with plasma vitamin B 6 concentrations below the lower normal range (3.6 mg/l) were recommended to take 50 mg of vitamin B 6 / day orally in addition to continuation of immunoglobulin substitution. Three months later, all treated and untreated participants were re-evaluated with regard to plasma concentrations of vitamin B 6 , serum immunoglobulin concentrations and absolute number of lymphocyte subsets in peripheral blood. Also, the participants were asked to answer the questionnaire again.
Statistical methods
The CVID patients were segregated into those with normal and pathological values for vitamin B 6 plasma concentration. Association of presence of vitamin B 6 deficiency with sprue-like disease, sarcoidosis-like complications, nodular follicular lymphoid hyperplasia of the intestine and sex was calculated using w 2 test. Furthermore, association of vitamin B 6 concentrations with age, body mass index and frequency of bowel movements, absolute number of CD4, CD8, CD16 and CD20 þ lymphocyte populations in peripheral blood of CVID patients was calculated using nonparametric (Spearman) correlation, respectively. Finally, two-tailed paired t-test was used to calculate the significance of changes of CD4, CD8, CD16 and CD20 þ lymphocyte populations and IgG and IgG subclasses, IgA, IgM serum concentrations before and after substitution of vitamin B 6 . Only P-values of o0.05 were regarded as significant.
Results
Concentration of vitamin B 6 in CVID patients and controls
Plasma concentration of vitamin B 6 was reduced in 17 of 54 CVID patients (Figure 1 ). Three out of the 37 patients with normal vitamin B 6 concentration had been taking oral vitamin substitution before the study. Therefore, the prevalence of vitamin B 6 deficiency in nonsubstituted CVID patients was 17 of 51 (33%). Reduction of vitamin B 6 was not associated with age, sex, body mass index, frequency of bowel movements, presence of complications of CVID associated with malabsorption (sprue-like disease 2/17 vs Association of common variable immunodeficiency J Bierwirth et al 3/37, sarcoidosis-like complications 4/17 vs 8/37, nodular follicular lymphoid hyperplasia of the intestine 1/17 vs 3/37; data not shown). Also, vitamin B 6 deficiency was not associated with absolute number of CD4, CD8, CD16 and CD20 þ lymphocyte populations in peripheral blood (data not shown).
Increase of CD4 cells after substitution of vitamin B 6
All 17 patients with vitamin B 6 deficiency were recommended to take 50 mg of vitamin B 6 per day. Twelve of the patients followed our advice. One of these patients stopped vitamin B 6 intake because of headache, which resided immediately after interruption of vitamin B 6 substitution. All other 11 patients had no side effects and after 3 months had a normal concentration of vitamin B 6 in plasma (43.6 mg/l) (Figure 2 ). Five of the 11 patients reached even high plasma concentrations of vitamin B 6 after substitution (Figure 2 ). In the 11 patients treated with vitamin B 6 , absolute numbers of CD4 þ lymphocytes increased significantly (P ¼ 0.016) (Figure 3 ). In contrast, numbers of CD8 þ , CD16 þ and CD20 þ lymphocyte subsets were not affected (not shown). Serum concentrations of IgG including all subclasses, IgA and IgM also did not increase (data not shown). Rate of infections as well as number of antibiotic treatments (none in the 11 patients in 6 months of followup) was not affected.
Discussion
In animal experiments, vitamin B 6 depletion reduced serum immunoglobulin concentrations (Trakatellis et al., 1992; Frydas et al., 1999) . The association of vitamin B 6 reduction with hypogammaglobulinemia in humans therefore raised the possibility that vitamin B 6 reduction may be a cause of CVID. However, substitution of vitamin B 6 did not improve serum immunoglobulin concentrations, at least not within the 3 months of follow-up in this study. Meanwhile, the majority of the patients have even been followed for more than 1 year, and in these patients, immunoglobulin concentrations still have not changed. Therefore, vitamin B 6 deficiency appears to be the consequence rather than the cause of CVID and certainly cannot replace immunoglobulin substitution. Vitamin B 6 deficiency is not caused by diets of the patients, which were not different in patients with and without vitamin B 6 deficiency. Also, there was no difference in body mass index or frequency of bowel movements. Enhanced inflammatory activity may be a cause of vitamin B 6 deficiency, as recently shown in rheumatoid arthritis (Chiang et al., 2005) . Furthermore, malabsorption may contribute to vitamin B 6 deficiency, as many CVID patients suffer from celiac-like disease, intestinal lymphoid hyperplasia or infections of the gut. However, the uptake of vitamin B 6 cannot be severely impaired, as oral substitution of the vitamin immediately normalized plasma concentrations. Surprisingly, patients had no symptoms suggesting vitamin B 6 deficiency such as dermatitis, glossitis, depression or anemia. Vitamin B 6 appears to be particularly important for CD4 þ T lymphocytes. Their number increased significantly after vitamin substitution; however, this result has to be viewed with caution after Bonferroni's correction for multiparameter analysis. In light of the high prevalence of vitamin B 6 reduction in CVID, screening for vitamin B 6 deficiency may be indicated, as the vitamin appears to be involved in prevention of atherosclerosis via its influence on homocysteine levels (Selhub et al., 1995) . 
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